Skip to content

Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer

Promoting Weight Loss Through Diet and Exercise in Overweight Women With Breast Cancer: A Four-arm Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02622711
Acronym
InForma
Enrollment
262
Registered
2015-12-04
Start date
2015-11-30
Completion date
2019-06-30
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, obesity, weight control, exercise and physical fitness

Brief summary

The investigators aim to evaluate the effect of a 6-month intervention (counseling) focused on weight loss in a group of overweight or obese women previously treated for early breast cancer. Intervention is designed to improve adherence to a healthy diet or/and to increase physical activity and decrease sedentary time, taking advantage of a pedometer-like device.

Detailed description

The InForma project is designed as a mono-institutional randomized controlled 4-arm parallel-group trial. Potential study participants will be recruited among all overweight or obese breast cancer patients previously treated at the European Institute of Oncology (IEO). Potential study participants will be recruited after breast cancer treatments (surgery, chemotherapy and and/or radiation) will be completed. Study participants will be randomized to one of the 4 arms: DI - Dietary Intervention; PAI - Physical Activity Intervention; PADI - Physical Activity and Dietary Intervention; LII - Less Intensive Intervention. Enrolled patients will receive a 6-month intervention and will be followed until the end of the study period with two additional follow-up visits at 12- and 24-month. The main aim of the study is to evaluate the impact of the intervention programme on body weight change in overweight or obese breast cancer patients.

Interventions

BEHAVIORALDI

Participants will be offered an individualized dietary counselling according to their lifestyle habits to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.

BEHAVIORALPAI

Participants will be offered an individualized physical activity counseling according to their lifestyle habits to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.

BEHAVIORALPADI

Participants will be offered an individualized dietary and physical activity counseling to reduce weight consisting of face-to face contacts, group meetings, motivational phone calls and information pamphlets.

BEHAVIORALLII

Participants will be considered as control group. They will receive a general healthy counselling providing materials and guidelines available for the general public.

Sponsors

Associazione Italiana per la Ricerca sul Cancro
CollaboratorOTHER
European Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* diagnosed with a first invasive non-metastatic breast carcinoma histologically confirmed, * BMI \> 25, * within 6-month/one year of completion of main cancer treatment, * being able to participate in the intervention, * agree to wear the wrist-based activity monitor during the study period, * agree to be randomized to either group, * written informed consent.

Exclusion criteria

* severe medical condition or advanced age impeding the patient to adhere at the planned study follow-up period, * contraindications to exercise due to history of heart condition, stroke, chest pain during activity or rest, severe hypertension * orthopaedic disability that would prevent optimal participation in the physical activities prescribed, * patient is unable to find transportation to the study location over the study period, - or * plans to move away from Lombardy or to be out of town for more than 3 weeks during the study period.

Design outcomes

Primary

MeasureTime frameDescription
Body weight reductionbaseline - 6 monthweight loss ≥5% of the baseline body weight via calibrated scales, stadiometer

Secondary

MeasureTime frameDescription
Long-term body weight controlbaseline - 12 month - 24 monthlong-term weight control or maintenance via calibrated scales, stadiometer
Pedometer Step Countbaseline - 6 month - 12 month - 24 monthchange in total step count via pedometer device with electronic data transmission
Dietary intakebaseline - 6 month - 24 monthchange in dietary intake via Food Frequency Questionnaire
Quality of lifebaseline - 6 month - 12 month - 24 monthchange in quality of life via Functional Assessment of Cancer Therapy-Breast (FACT-B)
Moodbaseline - 6 month - 12 month - 24 monthchange in mood via State-Trait Anxiety Inventory (STAI) questionnaires
Physical activity levelbaseline - 6 month - 12 month - 24 monthchange in physical activity and inactivity levels via IPAQ-International physical activity questionnaire
Oestradiol levelbaseline - 6 month - 24 monthchange in oestradiol assessed by blood samples
Insulin levelbaseline - 6 month - 24 monthchange in insulin assessed by blood samples
Glucose levelbaseline - 6 month - 24 monthchange in glucose assessed by blood samples
C-reactive protein levelbaseline - 6 month - 24 monthchange in C-reactive protein assessed by blood samples
Lipid Marker Changebaseline - 6 month - 24 monthchange in LDL, HDL, triglycerides and cholesterol assessed by blood samples

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026